Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Researchers from Kuopio University, Department of Medicine report on findings in cancer gene therapy
June 2nd, 2009
Researchers detail in 'Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer,' new data in cancer gene therapy. "Vascular endothelial growth factor (VEGF) has been shown to stimulate angiogenesis and myocardial perfusion. The short-term safety of VEGF gene therapy is excellent," scientists in Kuopio, Finland report. "However, there are only limited results regarding the long-term effects. The Kuopio Angiogenesis Trial (KAT) studied the efficiency and short-term safety of the local VEGF-A(165) gene transfer in 103 patients with coronary artery disease. Three patient groups received either VEGF as an adenoviral...
Source: Cancer Weekly (2009-06-02)
|
